159. Pneumococcal Disease and Prevention
Saturday, October 5, 2013: 8:30 AM-10:00 AM
Room: The Moscone Center: 135 (Hall E)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the use and impact of pneumococcal vaccines in children and adults
  • identify the impact of pneumococcal vaccines on the selection of circulating serotypes
  • identify appropriate vaccines for specific groups

Target Audience: vaccinologists, scientists, researchers, public health practitioners, pharmacists, nurses, microbiologists, members-in-training, lab personnel, investigators, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, hospital administrators, HIV clinicians, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Andrew Pavia, MD, FIDSA, FSHEA, University of Utah School of Medicine and Matthew Moore, MD, MPH, Centers for Disease Control and Prevention

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-095-L01-P


A. Pavia, None

M. Moore, None

D. M. Weinberger, Pfizer: Grant Investigator, Research grant

S. Halperin, Pfizer: Investigator, Research grant
Merck: Investigator, Research grant

M. M. Farley, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.